Smithbridge Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.06M Sell
5,883
-276
-4% -$282K 0.96% 32
2026
Q1
$5.66M Sell
6,159
-6,462
-51% -$6.55M 0.84% 36
2025
Q4
$13.6M Buy
12,621
+146
+1% +$140K 1.16% 31
2025
Q3
$9.52M Sell
12,475
-312
-2% -$232K 1.38% 26
2025
Q2
$9.97M Sell
12,787
-665
-5% -$517K 1.74% 16
2025
Q1
$11.1M Buy
+13,452
New +$11.2M 2.06% 12
2024
Q3
$12.7M Buy
14,304
+6,143
+75% +$5.52M 2.18% 11
2024
Q2
$7.39M Sell
8,161
-1,455
-15% -$1.16M 1.54% 20
2024
Q1
$7.48M Sell
9,616
-519
-5% -$369K 1.54% 20
2023
Q4
$5.91M Sell
10,135
-144
-1% -$84.1K 1.35% 22
2023
Q3
$5.52M Sell
10,279
-687
-6% -$354K 1.37% 20
2023
Q2
$5.14M Sell
10,966
-113
-1% -$47.4K 1.2% 29
2023
Q1
$3.81M Buy
11,079
+81
+0.7% +$27.3K 0.95% 39
2022
Q4
$4.02M Buy
+10,998
New +$3.9M 1.07% 35

Other funds holding LLY

Smithbridge Asset Management's LLY Position: Q2 2026 in Review

Smithbridge Asset Management reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $282K and leaving 5,883 shares worth $7.06M. The position accounts for 0.96% of the portfolio, ranked #32.

Smithbridge Asset Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $13.6M in Q4 2025. 2,373 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Smithbridge Asset Management held 5,883 shares of Eli Lilly worth $7.06M as of Q2 2026.
  • Smithbridge Asset Management sold 276 Eli Lilly shares in Q2 2026, an estimated $282K.
  • Eli Lilly made up 0.96% of Smithbridge Asset Management's portfolio in Q2 2026, its #32 holding.
  • Smithbridge Asset Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Smithbridge Asset Management's Eli Lilly position peaked at $13.6M in Q4 2025.
  • 2,373 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.